26 September 2023
Accrol Group Holdings plc (“Accrol” or the “Group”) FINAL RESULTS 2023 FY24 EBITDA now expected to be ahead of previous Board expectations, driven by…
Interim management report Economies, markets & Merchants’ performance Shareholders will recall that in the Full Year report to 31 January 2023 I was able…
26 September 2023 RESULTS FOR THE YEAR ENDED 31 MAY 2023 Third year of like for like revenue growth Continued strategic progress against a…
Adrian Sainsbury, Chief Executive, said: “We have performed well in the second half, with an acceleration of loan book growth, strong margins and a…
25 September 2023
Japan’s Ministry of Health, Labour and Welfare approves GSK’s Arexvy, the country’s first respiratory syncytial virus (RSV) vaccine for older adults · Arexvy’s approval will help protect…
25 September 2023 · Aviva to acquire AIG’s UK protection business for consideration of £460m · Supports Aviva’s strategy to grow capital-light businesses · Accelerates Aviva’s growth…
22 September 2023
22 September 2023 Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in…
21 September 2023
JD SPORTS FASHION PLC UNAUDITED INTERIM RESULTS FOR THE 26 WEEKS TO 29 JULY 2023 JD Sports Fashion Plc (the ‘Group’), the leading retailer…